Recently we concluded that an elevated IgA antibody response and the age of the infected individual (a total sum score of seven times IgA titre plus individual's age greater than or equal to 50.0) appeared to be of diagnostic value for (early) detection of LGV proctitis.1 Statistical
analyses showed that the use of this total sum score had high diagnostic accuracy. As published previously, over 85% of th...
Recently we concluded that an elevated IgA antibody response and the age of the infected individual (a total sum score of seven times IgA titre plus individual's age greater than or equal to 50.0) appeared to be of diagnostic value for (early) detection of LGV proctitis.1 Statistical
analyses showed that the use of this total sum score had high diagnostic accuracy. As published previously, over 85% of the Rotterdam population of patients with L2 proctitis reported symptoms (rectal discharge and bleeding) and more than 70% had clinical manifestations (discharge and
perianal erythema).2
We agree with Henry J. de Vries and co-workers and acknowledge the need for 'simple and affordable diagnostic procedures to screen the (asymptomatic) population at risk'.3 Our data show that Chlamydia-specific IgA antibody titers can be adequately used for the early discrimination
between LGV and non-LGV proctitis, a clear reflection of the more invasive character of the LGV serovars.1 Therefore, one might postulate that our sum score can not serologically discriminate between LGV and non-LGV serovars in persons without mucosal abnormalities. After all, there must
be at least some degree of tissue invasion (together with visible mucosal abnormalities, such as erythema or ulceration), before a significant antibody response can be mounted.
De Vries et al. did not use the same test as we did in our study. Although both tests use synthetic peptides and a similar format, the test we used, the Savyon test, incorporates more LGV-specific epitopes. In theory, the Sayvon test should be more specific for LGV diagnosis. The
conclusion of De Vries et al. that serology in general is of no diagnostic value is premature. The correct conclusion is that the Medac test might not be suitable for LGV diagnostic purposes.
We reanalyzed the data of the 24 Rotterdam patients with LGV proctitis. Only one patient reported no symptoms and had no clinical manifestations of proctitis on examination (patient A). Three patients had symptoms although no clinical manifestations were seen in proctoscopic examination (patient B, C and D). One patient had no symptoms while a mucosal ulcer was seen at proctoscopy (patient E). The total sum score in
all rectal LGV patients ranged from 47.7 to 96.2 with a median score of 61.7. Two of the LGV patients did not fulfill the criterion of a score greater than or equal to 50.0 as was reported in our paper.1 Patient A had a sum score of 63.5, just above the median score. Patient B,
C and D had a sum score of 55.8, 71.6 and 87.7 respectively. Patient E had a sum score of 68.2. The age of patient A to E did not differ from the other rectal LGV patients (p = 0.19). Though numbers are small, there seems to be no relation between self-reported symptoms, clinical
manifestations on proctoscopy and our sum score in the Rotterdam LGV patients. Other researchers also recommend the use of serology.4,5,6,7
The conclusion of our paper was that an increased IgA antibody response and the age of the infected individual are of possible diagnostic value for (early) detection of LGV proctitis.1 Simply put: if you find a high titer you have a high chance for LGV. We do not, however, recommend testing for IgA in order 'to exclude LGV' as suggested by De Vries et al.
In conclusion: a total sum score of seven times IgA titer plus individual's age greater than or equal to 50.0 appeared to be a simple,accurate and affordable diagnostic procedure to discriminate between chlamydial proctitis with serovar L2 and non-LGV serovars in a high-risk
population of MSM and is of possible diagnostic value for (early) detection of LGV proctitis, even in the absence of symptoms.
References
1. Van der Snoek EM, Ossewaarde JM, Van der Meijden WI, Mulder PGH, Thio HB. The use of serologic titers of IgA and IgG in (early) discrimination between rectal infection with non-LGV and LGV serovars of Chlamydia trachomatis. Sex Transm Infect 2007;83:330-4.
2. Waalboer R, Van der Snoek EM, Van der Meijden WI, Mulder PGH, Ossewaarde JM. Analysis of rectal Chlamydia trachomatis serovar distribution including L2 (lymphogranuloma venereum) at the Erasmus MC STI
clinic, Rotterdam. Sex Transm Infect 2006;82:207-11.
3. De Vries HJ, Smelov V, Morré SA. Electronic letter, Sex Transm Infect 28 augustus 2007.
4. Forrester B, Pawade J, Horner P. The potential role of serology in diagnosing chronic lymphogranuloma venereum (LGV): a case of LGV mimicking Crohn's disease. Sex Transm Infect 2006;82:139-40.
5. Halioua B, Bohbot JM, Monfort L, Nassar N, de Barbeyrac B, Monsonego J, Sednaoui P. Ano-rectal lymphogranuloma venereum: 22 cases reported in a sexually transmitted infections center in Paris. Eur J Dermatol 2006;16:177-80.
6. Spornraft-Ragaller P, Luck C, Straube E, Meurer M. Lymphogranuloma venereum. Two cases from Dresden. Hautarzt 2006;57:1095-100.
7. Den Hollander JG, Ossewaarde JM, de Marie S. Anorectal ulcer in HIV patients, don't forget lymphogranuloma venereum! AIDS 2004;18:1484-5.
E.M. van der Snoek,
J.M. Ossewaarde,
W.I. van der Meijden,
P.G.H. Mulder and H.B. Thio
Eric M. van der Snoek,
Dermatologist-Venereologist,
Department of Dermatology and Venereology,
Erasmus MC, Rotterdam, the Netherlands.
In 1985, I first suggested that vulnerability to AIDS and homosexuality may result from low DHEA. The first reports of low DHEA in AIDS appeared in 1989.
On average, DHEA is lower in male homosexuals than heterosexual men. I suggest that the continual loss of DHEA of AIDS actually produces the symptoms of AIDS.
Since there is overlap in DHEA levels, there should be some vulnerability...
In 1985, I first suggested that vulnerability to AIDS and homosexuality may result from low DHEA. The first reports of low DHEA in AIDS appeared in 1989.
On average, DHEA is lower in male homosexuals than heterosexual men. I suggest that the continual loss of DHEA of AIDS actually produces the symptoms of AIDS.
Since there is overlap in DHEA levels, there should be some vulnerability to HIV in heterosexuals as well as some protection in homosexual men exposed to the HIV. These vulnerabilities have been established. That is, some with low DHEA may be easily infected, some with medium DHEA may be infected but not develop AIDS, and some homosexual
men have been proven to have been exposed to the HIV but will mount an immune response that occurs even prior to antibody formation. This has been established.
I suggest testosterone reduces availability of DHEA. Therefore, black men, especially, and women should exhibit increased HIV infection rates as black men and women produce more testosterone than white men and women respectively. This also accounts for the large vulnerability to HIV
found in male homosexuals.
Screening for syphilis during pregnancy in Nigeria: a practice that must continue We read with interest the report from Osogbo in Nigeria (1). In our opinion and experience, we agree that this practice should not only continue but be improved upon. In a similar study on pregnant women done in Lagos, Nigeria (2), the incidence of positive syphilis test was about 3%. Serology for other possible sexually trans...
Screening for syphilis during pregnancy in Nigeria: a practice that must continue We read with interest the report from Osogbo in Nigeria (1). In our opinion and experience, we agree that this practice should not only continue but be improved upon. In a similar study on pregnant women done in Lagos, Nigeria (2), the incidence of positive syphilis test was about 3%. Serology for other possible sexually transmitted infections was done and reported as shown in Table1. While the antenatal patients in Osogbo made a captive audience, the report did not mention tracing and screening the male partners of the women positive for syphilis. Contact tracing of sexual partners is an important part of controlling the spread of sexually transmitted infections. This is not an easy exercise but it is essential. The prevalence of hepatitis B and HIV infections is high in sub-Saharan Africa. We suggest that following counselling and with patient consent, it is prudent to screen antenatal patients for these infections. Early detection and appropriate treatment will decrease maternal-fetal transmission of these infections.
References
1. Taiwo S.S, Adesiji O.O, Adekanle D.A. Screening for syphilis during pregnancy in Nigeria: a practice that must continue. Sex. Transm. Infect. 2007; 83: 357-358.
2. Opaneye A, Fabanwo A, Ashton V, Dada O. A. Seroprevalence of HIV and hepatitis B virus markers in Ikeja, Nigeria. Sexual Health Matters 2006; (7): 65-67. www.sexualhealthmatters.com
Abayomi Opaneye
Consultant in GU/HIV Medicine
Department of Genitourinary Medicine,
James Cook University Hospital,
Middlesbrough, England. TS4 3BW.
Adetokunbo Fabamwo
Senior Lecturer
Honorary Consultant Obstetrician and Gynaecologist,
Lagos State University College of Medicine/ Teaching Hospital,
Ikeja,
Lagos, Nigeria.
Recent reports on lymphogranuloma venereum (LGV) proctitis in men who have sex with men (MSM) have highlighted that affordable diagnostics for both symptomatic as well as asymptomatic LGV infections are urgently
needed. 1,2 LGV responds well to extensive antibiotic treatment but when untreated LGV can cause chronic or irreversible complications because of severe inflammation and invasive infection.3...
Recent reports on lymphogranuloma venereum (LGV) proctitis in men who have sex with men (MSM) have highlighted that affordable diagnostics for both symptomatic as well as asymptomatic LGV infections are urgently
needed. 1,2 LGV responds well to extensive antibiotic treatment but when untreated LGV can cause chronic or irreversible complications because of severe inflammation and invasive infection.3
In a recent interesting study, van der Snoek et al conclude that an elevated Chlamydia trachomatis (CT) IgA antibody response and the age of the infected individual are of possible diagnostic value for early detection of LGV proctitis. 4 Based on their study of 24 MSM with L2
proctitis and 15 MSM with rectal CT (non-LGV) infection, they suggest that the association between LGV L2 and significantly higher titers of IgA and IgG are caused by more invasive and more chronic inflammation of the
proctum due to the LGV biovar.
As published previously, and also mentioned in the article of van der Snoek, a considerable number of the patients with LGV proctitis in the present epidemic are asymptomatic.2,4,5 In a retrospective case controlled
study we found only 47% of the LGV cases had signs of proctitis (mucous membrane abnormalities) upon proctoscopic examination.2 Unfortunately the manuscript of van der Snoek fails to inform its readers on the patient complaints and/or clinical symptoms found among the included patients.
Their recommendation to test IgA levels in high risk populations to exclude LGV might therefore possibly miss a considerable number of asymptomatic cases of LGV proctitis with consequences for both the individual patient and the population at risk.
We previously studied MSM patients with any form of chlamydial proctitis and they were designated into 2 groups based upon mucous membrane abnormalities found during proctoscopic examination.5 In the group of 44 cases with mucous membrane abnormalities 32 had LGV proctitis and 12 had non-LGV chlamydial proctitis. In the group of 30 men without mucous membrane abnormalities, 13 had LGV proctitis and 17 had non-LGV proctitis. In the group with mucous membrane abnormalities IgG serology (C. trachomatis–IgG pELISA, Medac Diagnostika GmbH, Hamburg, Germany) had
a high positive predictive value for LGV proctitis (0,94) when a cut-off value of < 1:200 was used. However, in the group without mucous membrane abnormalities both the positive and negative predictive value were low (resp. 0,57 and 0,65). We concluded that IgG species-specific
serology could help support the LGV diagnosis when clinical symptoms are present but cannot be used for screenings purposes to detect LGV-infected persons without clinical symptoms.
In a second retrospective case controlled study performed by our group in Amsterdam, proctosopic examination and anal mucosal smears in MSM with receptive anal sex in the previous 6 months were found to be helpful to detect LGV proctitis.2 In that study 87 men with proctitis based on CT
serovar L2b men were compared with 2 separate control groups: MSM who had non-LGV Chlamydia proctitis (n = 377) and MSM who reported having receptive anorectal intercourse but who did not have anorectal chlamydia (n = 2677). Apart from HIV seropositivity, either proctitis detected by
proctoscopic examination or elevated >10 white blood cells/high-power field detected on an anorectal smear specimen were found to be the only clinically relevant predictors for LGV proctitis in MSM.
In the recently published IUSTI/WHO guideline on STI proctitis it is recommended to perform proctoscopy and anal mucosal smears in all MSM with receptive anal sex in the previous 6 months and to screen for anal chlamydia and gonorrhea.6 In case inflammatory signs and/or >10
leucocytes per high-power field upon microscopic examination of anal mucosal smears are detected presumptive treatment with doxycyclin is advised until the definite diagnosis become available. In case anal chlamydia is found, biovar determination of the chlamydia strain is indicated to confirm potential LGV proctitis.
In the ongoing LGV proctitis epidemic there is a great need for simple and affordable diagnostic procedures to screen the (asymptomatic) population at risk. Additional serological markers are required to evaluate as diagnostic tools for LGV proctitis in larger, well defined and
described cohorts. Until those studies are performed the gold standard for LGV diagnostics (both in symptomatic as well as in asymptomatic patients) remains molecular determination of chlamydia biovars.
References
1. Ward H, Martin I, Macdonald N, Alexander S, Simms I, Fenton K, French P, Dean G, Ison C. Lymphogranuloma venereum in the United kingdom.
Clin Infect Dis. 2007 Jan 1;44(1):26-32.
2. Van der Bij AK, Spaargaren J, Morré SA, Fennema HS, Mindel A, Coutinho RA, de Vries HJ. Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study. Clin Infect Dis. 2006 Jan 15;42(2):186-
94. Epub 2005 Dec 5.
3. Weir E. Lymphogranuloma venereum in the differential diagnosis of proctitis. CMAJ 2005; 172:185.
4. van der Snoek E, Ossewaarde J, van der Meijden W, Mulder P, Thio B. The use of serologic titers of IgA and IgG in (early) discrimination between rectal infection with non-LGV and LGV serovars of Chlamydia trachomatis.
Sex Transm Infect. 2007 Aug;83(4):330-4.
5. Spaargaren J, Fennema HS, Morré SA, de Vries HJ, Coutinho RA. New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam. Emerg Infect Dis. 2005 Jul;11(7):1090-2.
6. McMillan A, van Voorst Vader PC, de Vries HJ. The 2007 European Guideline (International Union against Sexually Transmitted Infections/World Health Organization) on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens.
Int J STD AIDS. 2007 Aug;18(8):514-20
Violence against women is a global problem, and rates in Southeast Asia is high enough.Patriarchy culture take a part for this condition. The culture is also contribute to the situation. Gender inequality is especially visible in developing countries. Women and girls often have less information and access to services, especially in rural areas. Girls make their sexual debut early, either through early ma...
Violence against women is a global problem, and rates in Southeast Asia is high enough.Patriarchy culture take a part for this condition. The culture is also contribute to the situation. Gender inequality is especially visible in developing countries. Women and girls often have less information and access to services, especially in rural areas. Girls make their sexual debut early, either through early marriage or sexual abuse. In most cases their partners are typically much older men. Physical and sexual violence within marriage are also common, and women have little
room to negotiate the use of condoms or to refuse sex to an unfaithful partner. Culture is not immutable, but change has to come from within a society,because people feel the need for it.Mobilization of local resources and indigenous knowledge, as well as the promotion of women's
creativity and productivity, can be vital tools in the prevention and control of HIV/AIDS amongst women. There is a strong need of media support, NGO, and government.
While sharing Adams and colleagues’ concerns about the use of major outcomes averted, I should like to point out a factual error in their description[1] of the results from the ClaSS model[2]. The definition of major outcome used in that report, which appears in the text on page 107
and in the caption to Figure 18 on page 108 of the report[2] excludes epididymitis. The “seemingly perverse” result that sc...
While sharing Adams and colleagues’ concerns about the use of major outcomes averted, I should like to point out a factual error in their description[1] of the results from the ClaSS model[2]. The definition of major outcome used in that report, which appears in the text on page 107
and in the caption to Figure 18 on page 108 of the report[2] excludes epididymitis. The “seemingly perverse” result that screening males in addition to females is more cost-effective than screening females alone is therefore based on an outcome measure that does not include epididymitis. While it is true that the cost of epididymitis is included in the calculations, the result cited still holds even if the cost of epididymitis is removed. In the interests of further clarity, I should also like to point out that we only considered screening males in addition to females: we never considered screening males alone.
References
[1] Adams E J, Edmunds W J, Turner K M. Commentary on “The cost-effectiveness of opportunistic chlamydia screening in England”. Sex Transm Infect 2007;83:275.
[2] Low N, McCarthy A, Macleod J, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital
chlamydial infection. Health Technology Assessment, 2007. Report No. 11(8).
I noticed an error in the editorial "Effective HIV prevention requires gender-transformative work with men" by Kristin L. Dunkle and Rachel Jewkes. The list should indicate that the first article referenced, "How men’s power over women fuels the HIV epidemic" by G.R. Gupta, is from the 324th, not the 321st, volume (issue 7331). At this time, your web site's Crossref link links to a review of a movie, 28...
I noticed an error in the editorial "Effective HIV prevention requires gender-transformative work with men" by Kristin L. Dunkle and Rachel Jewkes. The list should indicate that the first article referenced, "How men’s power over women fuels the HIV epidemic" by G.R. Gupta, is from the 324th, not the 321st, volume (issue 7331). At this time, your web site's Crossref link links to a review of a movie, 28 Days.
In addition to the confusion this may (and has) cause readers, it also detracts from the referenced author's citation record.
Recent Commentary in the journal (1) encourages wider implementation of nucleic acid amplification tests (NAATs) to detect gonorrhoea (GC). We have used GC NAATs (Gen-Probe APTIMA Combo2) since 2003, with high uptake, in a Liverpool chlamydia screening population and with referral of GC
positives to our local Genitourinary Medicine (GUM) clinic for management (2). We have now observed a doubling of femal...
Recent Commentary in the journal (1) encourages wider implementation of nucleic acid amplification tests (NAATs) to detect gonorrhoea (GC). We have used GC NAATs (Gen-Probe APTIMA Combo2) since 2003, with high uptake, in a Liverpool chlamydia screening population and with referral of GC
positives to our local Genitourinary Medicine (GUM) clinic for management (2). We have now observed a doubling of female cases of GC and a reversal of the downward trend for male GC as reported through KC60 - the national
indicator of GC activity which is based on central reporting but essentially only of cases seen at GUM clinics. For females (Fig 1), compared to a four year average baseline (2000-2003) of 101 cases per annum, KC60 reports showed an extra 51 cases in 2004 and an extra 99 cases in 2005. These extra numbers reflect closely the 45 cases in 2004 and the
107 cases in 2005 detected by concomitant screening for GC in the community chlamydia screening programme. For males (Fig 2), the upturn in KC60 reports can be matched to the total of cases detected directly by community screening plus by contact tracing of female community cases (assumed 50% success).
This significant local impact on detection of GC cases suggests that concomitant / dual testing in the community can benefit the wider provision of services for Sexual Health. Empirical evidence gained from screening in Liverpool has been recognised by the Cheshire and Merseyside
Sexual Health Network; the development of a Care Pathway for asymptomatic low-risk individuals recommends concomitant screening for chlamydia and gonorrhoea using APTIMA (3). This facilitates prompt, easy access to more comprehensive screening for sexually transmitted infections at a wide
range of venues, and may also promote opportunities for increased participation in the National Chlamydia Screening Programme.
Also with regard to data collection, KC60 data is an important tool in assessing progress towards the Department of Health target for a twenty-five percent reduction in cases of GC diagnosed at GUM clinics (4). Consideration of changes to KC60 reporting may be needed to prevent increased use of GC NAATs and/or dual testing in the community becoming a confounder to monitoring of this aim.
Figure 1
Figure 2
References
1. Bignell CJ, Sex Transm Infect 2007;83:179-80.
2. Lavelle SJ, Jones KE, Mallinson H et al. Finding, confirming and managing gonorrhoea in a population screened for chlamydia using the Gen-Probe Aptima Combo2 assay. Sex Transm Infect 2006;82:221-4.
3. Abbott, M (on behalf of the Care Pathways Working Group) Cheshire and Merseyside Sexual Health Network: STI Care Pathways explanatory document. 2007. Available at:
http://www.cmshn.nhs.uk/document_uploads/Care%20Pathways/CMSHNCarePath_1.pdf
4. Department of Health, Better prevention better services better sexual health: the national strategy for sexual health and HIV. London: DOH, 2001
In the June 2007 issue of Sexually Transmitted Infections, Dunkle and Jewkes make a much needed case for increased attention to the role of gender-based violence (GBV) in fueling the HIV pandemic. In their editorial, Dunkle and Jewkes assert that "social ideals of asculinity,"
including, inter alia, heterosexual success with women in the context of an entrenched gender hierarchy and the ability to contro...
In the June 2007 issue of Sexually Transmitted Infections, Dunkle and Jewkes make a much needed case for increased attention to the role of gender-based violence (GBV) in fueling the HIV pandemic. In their editorial, Dunkle and Jewkes assert that "social ideals of asculinity,"
including, inter alia, heterosexual success with women in the context of an entrenched gender hierarchy and the ability to control women, is an underlying cause of the observed association between violence perpetration
and sexual risk taking among men. Referring to an article published in the same issue of Sexually Transmitted Infections regarding gender-based violence and STI risk in Bangladesh, they find mounting evidence for national generalizability across a range of cultural settings "supporting the link between perpetration of GBV and STI/HIV risk". Lastly, they recommend replicating gender transformative interventions with men, such as the Stepping Stones program, in order to address the underlying causes
of gendered HIV risk, namely repressive gender norms and socioeconomic inequality that serve to disempower women vis-á-vis men. Their commentary is welcome, especially in a policy climate that is increasingly turning towards biomedical and non-gender transformative solutions to HIV, such as male circumcision to stem the tide of a continually mounting epidemic.
While agreeing with the spirit of their editorial, I question the logic that they use to derive their recommendations and propose an alternative method for analyzing the relationship among social ideals of
masculinity, gender-based violence and HIV/STI transmission using an ecologic and comparative framework to explain population-level variations in GBV and HIV risk.
Dunkle and Jewkes accurately point to the growing body of evidence that demonstrates unequivocally that women who experience GBV and gender inequitable attitudes are at greater risk of HIV at the individual level. However, despite this association at the individual level, at the ecologic level it does not necessarily hold that countries or regions with high rates of GBV/gender inequality experience heightened rates of HIV/STIs. For instance, although the WHO multi-country study on GBV has found that
Bangladesh has among the highest rates of GBV of the countries studied1 (findings reinforced in the Silverman et al study), Bangladesh as of 2005 has a negligible national HIV prevalence rate of <0.1% (see table 1). Evidence suggests that Muslim societies, though often endorsing highly repressive gender norms, have extremely low rates of HIV/STIs.2 In fact, it may be the repressive sexual culture of these countries/regions that is protective against HIV, limiting opportunities for marital infidelity and
sexual liberty.
Likewise, the WHO multi-country study found Ethiopia’s and Peru’s prevalence of intimate partner violence to be the highest of the ten countries under study respectively; yet, adult HIV prevalence was estimated at 4.4% in Ethiopia in 2003 and 0.6% in Peru as of 2005. Countries with higher national HIV prevalence rates, including Namibia
(19.6% in 2005) and Tanzania (6.5% in 2005), exhibited relatively lower rates of GBV (see table 1). Further, whereas HIV prevalence rates tend to be higher in urban areas,3 according to the WHO multi-country study
results, GBV is more common in rural (provincial) settings while urban residence appears to have a protective effect.
In essence, Dunkle and Jewkes’ comment commits the atomistic fallacy, or incorrectly generalizing an individual-level association to the group level.4 In order to assess the contribution of GBV to HIV at the ecologic level, studies must move from thinking about the replication of findings
in different settings to a comparative, population-level framework. The disciplines of sociology, political science and economics routinely use cross-national data to test hypotheses about variations in social phenomena across countries.5 In his classic piece “Sick Individuals and
Sick Populations”, epidemiologist Geoffrey Rose (1985) reminds us that the question,“‘Why do individuals have hypertension?’ is a quite different question from ‘why do some populations have much hypertension, whilst in
others it is rare?’”.6 In order to address this second question, Rose argues that “what distinguishes the two groups is nothing to do with the characteristics of individuals, it is rather a shift of the whole
distribution- a mass influence acting on the population as a whole.” In public health, cross-national comparisons can shed light on a host of important public health questions, including those related to GBV and HIV. To reframe Rose’s question, ‘Why are individuals who experience GBV more
likely to contract HIV?’ is a very different question from ‘Why do some countries experience higher rates of GBV and how does this affect population rates of HIV infection?’
In the case of HIV, it remains somewhat of a mystery how individual HIV risk factors link up to population risk. Ultimately, due to the limited number of transmission routes, some variation in behavior between populations, coupled with a tipping point and possible biomedical
transmissible cofactors must be responsible for the heightened rate of HIV in certain populations. More evidence is needed to explain under what conditions gender inequitable beliefs and behaviors link up with
population-level GBV and HIV risk.
Furthermore, interventions aimed at transforming a group level characteristic, such as repressive gender norms, should focus on interventions that address the ecologic or structural level.7 There is intuitively a contradiction inherent in using individual-level interventions to induce broad, socially transformative gender equality. Social change does not proceed one individual at a time, but rather when, in Rose’s words, there is a “mass influence causing a shift in the whole distribution”. In order to understand what that mass influence is, and to intervene at the population level, one must know what constitute the
population-level risk factors. More research must be conducted on why HIV prevalence rates vary so greatly within and between countries despite similar risk factors, such as high rates of GBV. Differences in collection and reporting of national HIV sero-prevalence estimates previously
hampered comparative research of cross-national HIV prevalence. However, new data sources, notably Demographic and Health Surveys (DHS) with linked HIV testing results are an extraordinarily rich, new data source that has
not yet been fully exploited to address questions regarding the social-structural and population-level determinants of HIV infection and GBV. Further, comparable national probability samples such as those utilized in
the DHS allow for national estimates of GBV that can facilitate cross-national and intra-national comparisons of ecologic-level risk factors.
This comment is in solidarity with Dunkle and Jewkes’ contention that “broad socially transformative programs that promote gender equality and discourage perpetration of gender-based violence and are needed to combat
the global HIV pandemic”. It is clear in countries with highly generalized HIV epidemics that reducing gender inequality and sexually empowering women are crucial to stem the spread of HIV. However, the modes by which to generate social transformation must stem from an understanding of the
macro-level causes of differing social phenomena across populations. Dunkle and Jewkes point to microbicides as a gender-sensitive technology, but one that fails to address the “underlying social constructions of gender”. To this I would add male circumcision, an anti-HIV intervention
increasingly gaining in prominence, which also fails to transform the broader constructions of gender in society and arguably has the potential to actually reinforce entrenched gender norms and male power. In keeping with recent literature, GBV should be addressed as a public health problem and human rights concern in its own right8 and not solely in relation to its instrumental association with reducing HIV and STI prevalence. Public health interventions that reinforce gender inequality and gendered power
relations should be eschewed in favor of gender transformative interventions that proceed at the population level.
References
1. World Health Organization. Summary Report, WHO multi-country study on women’s health and domestic violence against women: initial results on prevalence, health outcomes and women’s responses, 2005. Retrieved June
25, 2007, from
http://www.who.int/gender/violence/who_multicountry_study/en/index.html.
See also, Garcia-Moreno C, Jansen H, Ellsberg M. Prevalence of intimate partner violence: findings from the WHO multi-country study on women’s health and domestic violence, Lancet 2006; 368:1260-1269
2. Gray PB. HIV and Islam: is HIV prevalence lower among Muslims? Soc Sci Med 2004;58:1751–1756.
3. Shelton JD, Cassell MM, Adetunji J. Is poverty or wealth at the root of HIV? Lancet 2005; 366(9491): 1057.
4. Leyland AH, Groenewegen PP. Multilevel modeling and public health policy, Scandinavian Journal of Public Health 2003; 31(4):267-274.
5. e.g., Dogan M, Pelassy D. How to compare nations: strategies in comparative politics. New Jersey: Chatham House Publishers, 1984.
6. Rose G. Sick individuals and sick populations, Int J Epidemiol 2001;30:427-432.
7. Blankenship KM, Friedman SR, Dworkin S, et al. Structural Interventions: Concepts, Challenges and Opportunities for Research,
Journal of Urban Health 2006;83(1):59-72.
8. Brundtland GH. Violence, health, and human rights: toward a shared agenda for prevention, Health and Human Rights: An International Journal 2003;6(2): 11-13.
Steve Slack’s article on “condomophobia” (1) raises important issues about condom use and safer sex. However, it needs qualifying.
A phobia is an irrational fear. Not using condoms because of a fear of them must be very rare- I have never seen a case in 36 years of clinical practice. More likely is fear of erectile failure while putting on a condom. I would suggest another common scenario for no...
Steve Slack’s article on “condomophobia” (1) raises important issues about condom use and safer sex. However, it needs qualifying.
A phobia is an irrational fear. Not using condoms because of a fear of them must be very rare- I have never seen a case in 36 years of clinical practice. More likely is fear of erectile failure while putting on a condom. I would suggest another common scenario for not using a condom
(apart from not having one at hand as Slack correctly suggests may happen) it is that the person, partner or couple are carried away by the heightened feelings of the sexual event. Other possible reasons for not using condoms are fear of the partner’s reaction (“why are you using one
of those, I’m not infected- are you?”), that sex without a condom feels more pleasurable than wearing one, and being romantically in love with the partner (2).
Slack quotes from the ancient Egyptians. At about the same time (i.e. 1300BC) the Bible (Deuteronomy 21.10) discusses what an Israelite should do when he captures a woman in battle and “desires” her . Sexual desire
may be an almost overwhelming urge unless checked by restraining cognitive inputs. Romantic love, sexual desire and arousal are monoamine (principally dopamine and serotonin) associated events in cortical and
limbic system brain areas, some of which are very similar in terms of neurotransmitter profile to obsessive compulsive disorders (2) or hypomania. The themes of desire/arousal/love opposed by cognitive inputs condense at any one sexual scenario to form a final decision pathway i.e. the use or non use of condoms.
Slack sites car seat belt usage and inserting lipstick and mobile phones into personal bags as examples of common automatic practices. I would suggest that personal motivation lies behind most seat belt usage (“this might save my life”) and that anticipated pleasure lies behind
inserting the more personal objects into bags – back to dopamine again!
The war against unsafe sex was temporarily won in the early 1980s in the UK because people feared they would die of HIV. What higher motivation could there be for using a condom? Nowadays all STIs can be treated and have a relatively good prognosis. This means we must again increase
motivation- and this is really the linchpin underlying condom use. Motivational counselling for using condoms (3), as well as putting them in bags as Slack correctly suggests, is the correct way forward.
References
1. Slack S .“Condomophobia”. Sex Transm Infect 2007;83:246
2. Goldmeier D , Richardson D . Romantic love and sexually transmitted infection acquisition: hypothesis and review. Int J STD AIDS 2005;16:585-587
3. Petersen R, Albright J, Garrett JM, Curtis KM Pregnancy and STD prevention couseling using an adaptation of motivational interviewing: a randomised controlled trial. Perspect Sex Reprod Health 2007;39:21-28
Dear Editor,
Recently we concluded that an elevated IgA antibody response and the age of the infected individual (a total sum score of seven times IgA titre plus individual's age greater than or equal to 50.0) appeared to be of diagnostic value for (early) detection of LGV proctitis.1 Statistical analyses showed that the use of this total sum score had high diagnostic accuracy. As published previously, over 85% of th...
Dear Editor,
In 1985, I first suggested that vulnerability to AIDS and homosexuality may result from low DHEA. The first reports of low DHEA in AIDS appeared in 1989.
On average, DHEA is lower in male homosexuals than heterosexual men. I suggest that the continual loss of DHEA of AIDS actually produces the symptoms of AIDS.
Since there is overlap in DHEA levels, there should be some vulnerability...
Dear Editor,
Screening for syphilis during pregnancy in Nigeria: a practice that must continue We read with interest the report from Osogbo in Nigeria (1). In our opinion and experience, we agree that this practice should not only continue but be improved upon. In a similar study on pregnant women done in Lagos, Nigeria (2), the incidence of positive syphilis test was about 3%. Serology for other possible sexually trans...
Dear Editor,
Recent reports on lymphogranuloma venereum (LGV) proctitis in men who have sex with men (MSM) have highlighted that affordable diagnostics for both symptomatic as well as asymptomatic LGV infections are urgently needed. 1,2 LGV responds well to extensive antibiotic treatment but when untreated LGV can cause chronic or irreversible complications because of severe inflammation and invasive infection.3...
Dear Editor,
Violence against women is a global problem, and rates in Southeast Asia is high enough.Patriarchy culture take a part for this condition. The culture is also contribute to the situation. Gender inequality is especially visible in developing countries. Women and girls often have less information and access to services, especially in rural areas. Girls make their sexual debut early, either through early ma...
Dear Editor,
While sharing Adams and colleagues’ concerns about the use of major outcomes averted, I should like to point out a factual error in their description[1] of the results from the ClaSS model[2]. The definition of major outcome used in that report, which appears in the text on page 107 and in the caption to Figure 18 on page 108 of the report[2] excludes epididymitis. The “seemingly perverse” result that sc...
Dear Editor
I noticed an error in the editorial "Effective HIV prevention requires gender-transformative work with men" by Kristin L. Dunkle and Rachel Jewkes. The list should indicate that the first article referenced, "How men’s power over women fuels the HIV epidemic" by G.R. Gupta, is from the 324th, not the 321st, volume (issue 7331). At this time, your web site's Crossref link links to a review of a movie, 28...
Dear Editor,
Recent Commentary in the journal (1) encourages wider implementation of nucleic acid amplification tests (NAATs) to detect gonorrhoea (GC). We have used GC NAATs (Gen-Probe APTIMA Combo2) since 2003, with high uptake, in a Liverpool chlamydia screening population and with referral of GC positives to our local Genitourinary Medicine (GUM) clinic for management (2). We have now observed a doubling of femal...
Dear Editor,
In the June 2007 issue of Sexually Transmitted Infections, Dunkle and Jewkes make a much needed case for increased attention to the role of gender-based violence (GBV) in fueling the HIV pandemic. In their editorial, Dunkle and Jewkes assert that "social ideals of asculinity," including, inter alia, heterosexual success with women in the context of an entrenched gender hierarchy and the ability to contro...
Dear Editor,
Steve Slack’s article on “condomophobia” (1) raises important issues about condom use and safer sex. However, it needs qualifying.
A phobia is an irrational fear. Not using condoms because of a fear of them must be very rare- I have never seen a case in 36 years of clinical practice. More likely is fear of erectile failure while putting on a condom. I would suggest another common scenario for no...
Pages